BCL2L10 and melanoma: Interestingly, analysis of microarray data generated from A375 melanoma cells treated with siRNAs against 45 transcription factors and signaling molecules (GSE31534) [31] revealed that the silencing of STAT3 markedly reduced BCL2L10 mRNA levels (Figure 3A).